CareLit Fachartikel

Role of IGF1 in primary ovarian cancer – a study of the OVCAD European Consortium

I Rohr, R Zeilinger, M Heinrich, R Richter, N Concin, I Vergote, S Mahner, T Van Gorp, F Trillsch, D Cacsire-Tong, R Chekerov, J Sehouli, EI Braicu · Geburtshilfe und Frauenheilkunde · 2014 · Heft 09

Dokument
1113925
CareLit-ID
Jahr
2014
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Geburtshilfe und Frauenheilkunde
Autor:innen
I Rohr, R Zeilinger, M Heinrich, R Richter, N Concin, I Vergote, S Mahner, T Van Gorp, F Trillsch, D Cacsire-Tong, R Chekerov, J Sehouli, EI Braicu
Ausgabe
Heft 09 / 2014
Seiten
–
Erschienen: 2014-09-05 00:00:00
ISSN
0016-5751

Zusammenfassung

Introduction: IGF1 (insulin growth factor 1) is a hormone crucially involved in the physiology of cellular proliferation. Moreover, deregulation of IGF1 was shown to be relevant in the carcinogenesis of various tumor entities including breast cancer. However, the impact in the pathophysiology of ovarian cancer is unclear. Therefore we investigate the predictive and prognostic role of IGF1 circulatory levels in a collective of 275 primary epithelial ovarian cancer (EOC) patients. Methods: In the FP6 European Multicentric Project "OVCAD", 275 consecutive patients with primary EOC were enrolled. Patients were eligi…

Schlagworte

Association Tumor Diagnosis Ascites Breast Geburtshilfe und Frauenheilkunde